X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease (vol 117, pg 53, 2011)

被引：0
|
作者：
Booth, C.
Gilmour, K. C.
Veys, P.
Gennery, A. R.
Slatter, M. A.
机构：
来源：
BLOOD | 2011年 / 118卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5060 / 5060
页数：1
相关论文
共 50 条
  • [31] A Unique Clinical Presentation of X-Linked Lymphoproliferative Syndrome With a Novel Mutation in SH2D1A and Review of the Literature
    Eckrich, Michael J.
    Yang, Elizabeth
    Domm, Jennifer
    Ho, Richard
    Calder, Cassie
    Manes, Becky
    Bleesing, Jack
    Frangoul, Haydar
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (01) : E39 - E42
  • [32] Skin Lesions in a Boy With X-linked Lymphoproliferative Disorder: Comparison of 5 SH2D1A Deletion Cases
    Mejstrikova, Ester
    Janda, Ales
    Hrusak, Ondrej
    Buckova, Hana
    Vlckova, Marketa
    Hancarova, Miroslava
    Freiberger, Tomas
    Ravcukova, Barbora
    Vesely, Karel
    Fajkusova, Lenka
    Kopeckova, Lenka
    Sumerauer, David
    Kabickova, Edita
    Sediva, Anna
    Stary, Jan
    Sedlacek, Zdenek
    PEDIATRICS, 2012, 129 (02) : E523 - E528
  • [33] Case Report: Novel Splicing Variant in SH2D1A in a Patient With X-Linked Lymphoproliferative Syndrome Type 1
    Kwon, Won Kyung
    Kim, Jee Ah
    Park, Jong-Ho
    Kim, Doo Ri
    Park, Su Eun
    Kim, Yae Jean
    Yoo, Keon Hee
    Jang, Ja-Hyun
    Kang, Eun Suk
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [34] CLINICAL FEATURES AND OUTCOME OF X-LINKED LYMPHOPROLIFERATIVE SYNDROME TYPE 1 (SAP DEFICIENCY) AND TYPE 2 (XIAP DEFICIENCY) IN JAPAN
    Kanegane, Hirokazu
    Yang, Xi
    Nishida, Naonori
    Ishii, Eiichi
    Miyawaki, Toshio
    PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : E78 - E78
  • [35] Exon skipping caused by a complex structural variation in SH2D1A resulted in X-linked lymphoproliferative syndrome type 1
    Wu, Liwen
    Yang, Feng
    Wang, Jia
    Yang, Fan
    Liang, Mengmeng
    Yang, Haiyan
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2022, 10 (03):
  • [36] Identification of a novel nonsense mutation in SH2D1A in a patient with X-linked lymphoproliferative syndrome type 1: a case report
    Lyu, Xiaodong
    Guo, Zhen
    Li, Yangwei
    Fan, Ruihua
    Song, Yongping
    BMC MEDICAL GENETICS, 2018, 19
  • [37] Maternal onset de novo SH2D1A mutation and lymphocytic choriomeningitis virus infection in a patient with X-linked lymphoproliferative disease type 1: A case report
    Liu, Jinrong
    Tian, Wenjun
    Wang, Fang
    Teng, Wen
    Zhang, Yang
    Tong, Chunrong
    Zhang, Chonglin
    Ju, Ying
    Zhang, Bingchang
    Zhao, Shunying
    Liu, Hongxing
    MOLECULAR MEDICINE REPORTS, 2015, 11 (05) : 3291 - 3294
  • [38] Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase
    Aoukaty, A
    Tan, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (15) : 13331 - 13337
  • [39] Potential pathogenic mechanism of type 1 X-linked lymphoproliferative syndrome caused by a mutation of SH2D1A gene in an infant: A case report
    Wang, Yanchun
    Wang, Yan
    Lu, Weimin
    Tao, Lvyan
    Xiao, Yang
    Zhou, Yuantao
    He, Xiaoli
    Zhang, Yu
    Li, Li
    MEDICINE, 2022, 101 (41) : E30951
  • [40] A Child with Hemophagocytic Lymphohistiocytosis and Suspected X-Linked Lymphoproliferative Disease Associated with C.131G>A Variant of Unknown Significance Involving The SH2D1A Gene
    Lim, M. A.
    Dowsett, L.
    Hooten, K.
    Wada, R.
    Hutchins, K.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S283 - S283
12345